Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Sandig

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Journal of Molecular Medicine (Berlin, Germany)|April 1, 1996
Liver-directed gene transfer and application to therapyV Sandig, M Strauss
Methods in Molecular Medicine|March 11, 2011
Combined adenoviral transfer of tumor suppressor and cell-cycle genes for tumor-cell apoptosisK Brand, V Sandig, M Strauss
European Journal of Biochemistry|October 1, 1993
A mutant T7 phage promoter is specifically transcribed by T7-RNA polymerase in mammalian cellsA Lieber, V Sandig, M Strauss
Biological Chemistry Hoppe-Seyler|March 1, 1996
Evaluation of HBV promoters for use in hepatic gene therapyP Löser, V Sandig, I Kirillova, et al.
Gene|September 15, 1993
A phage T7 class-III promoter functions as a polymerase II promoter in mammalian cellsV Sandig, A Lieber, S Bähring, et al.
Journal of Virology|January 7, 1998
Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaBP Löser, G S Jennings, M Strauss, et al.
The Journal of Clinical Investigation|September 18, 1997
Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implicationT Schöneberg, V Sandig, J Wess, et al.
Zeitschrift Fur Gastroenterologie|June 1, 1996
Gene therapy: prospects for treatment of liver diseaseV Sandig, C Hofmann, P Löser, et al.
Nature Medicine|March 1, 1997
Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell deathV Sandig, K Brand, S Herwig, et al.
Gene Therapy|November 1, 1996
HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor geneV Sandig, P Löser, A Lieber, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Journal of Molecular Medicine (Berlin, Germany)|April 1, 1996
Liver-directed gene transfer and application to therapyV Sandig, M Strauss
Methods in Molecular Medicine|March 11, 2011
Combined adenoviral transfer of tumor suppressor and cell-cycle genes for tumor-cell apoptosisK Brand, V Sandig, M Strauss
European Journal of Biochemistry|October 1, 1993
A mutant T7 phage promoter is specifically transcribed by T7-RNA polymerase in mammalian cellsA Lieber, V Sandig, M Strauss
Biological Chemistry Hoppe-Seyler|March 1, 1996
Evaluation of HBV promoters for use in hepatic gene therapyP Löser, V Sandig, I Kirillova, et al.
Gene|September 15, 1993
A phage T7 class-III promoter functions as a polymerase II promoter in mammalian cellsV Sandig, A Lieber, S Bähring, et al.
Journal of Virology|January 7, 1998
Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaBP Löser, G S Jennings, M Strauss, et al.
The Journal of Clinical Investigation|September 18, 1997
Reconstitution of mutant V2 vasopressin receptors by adenovirus-mediated gene transfer. Molecular basis and clinical implicationT Schöneberg, V Sandig, J Wess, et al.
Zeitschrift Fur Gastroenterologie|June 1, 1996
Gene therapy: prospects for treatment of liver diseaseV Sandig, C Hofmann, P Löser, et al.
Nature Medicine|March 1, 1997
Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell deathV Sandig, K Brand, S Herwig, et al.
Gene Therapy|November 1, 1996
HBV-derived promoters direct liver-specific expression of an adenovirally transduced LDL receptor geneV Sandig, P Löser, A Lieber, et al.
Pageof 3